Zhejiang Yatai Pharmaceutical (002370.SZ): Injected Ganciclovir Passes Generic Drug Consistency Evaluation.

25/02/2025

GMT Eight

Zhejiang Yatai Pharmaceutical (002370.SZ) announced that the company has recently received the Drug Supplementary Application Approval Notice for injection of Ganciclovir issued by the National Medical Products Administration. The injection of Ganciclovir by the company has passed the evaluation of generic drug quality and efficacy consistency.

Goldman Sachs Group, Inc.: Reiterates "Buy" rating on MNSO (MNSO.US), expecting smooth expansion of stores and progress in overseas business in the fourth quarter of 2024.

Nantong Chaoda Equipment (301186.SZ): Nanjing Youxu will become the controlling shareholder, and trading will resume on February 26th.

Contact: contact@gmteight.com

Zhejiang Yatai Pharmaceutical (002370.SZ): Injected Ganciclovir Passes Generic Drug Consistency Evaluation.

RECOMMEND

US Stock Market Move | Lower the price of small bottles of the weight loss drug Zepbound, Eli Lilly (LLY.US) rises more than 2% against the trend.

US Stock Market Move | In January, sales in Europe plummeted by 45%, causing Tesla, Inc. (TSLA.US) to drop nearly 6%.

Lianhua (00980) issued 360 million shares on February 24 in accordance with the subscription of domestic shares.